Introduction Blood production in humans culminates in the daily release of around 10 11
cells into the circulation, mainly platelets and red blood cells. All blood cells originate from a …

Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300
individuals per million births. With the exception of hemophilia and von Willebrand disease …

Chorea‐acanthocytosis (ChAc) is a severe, neurodegenerative disorder that shares clinical
features with Huntington's disease and McLeod syndrome. It is caused by mutations in …

Macrothrombocytopenia (MTP) is a heterogeneous group of disorders characterized by
enlarged and reduced numbers of circulating platelets, sometimes resulting in abnormal …

Background Heritable bleeding and platelet disorders (BPD) are heterogeneous and frequently
have an unknown genetic basis. The BRIDGE-BPD study aims to discover new causal …

Background: Pulmonary arterial hypertension (PAH) is a rare disease with an emerging
genetic basis. Heterozygous mutations in the gene encoding the bone morphogenetic protein …

The Src family kinase (SFK) member SRC is a major target in drug development because it
is activated in many human cancers, yet deleterious SRC germline mutations have not been …

Despite whole-genome sequencing (WGS), many cases of single-gene disorders remain
unsolved, impeding diagnosis and preventative care for people whose disease-causing …

Platelets are anuclear cells that are essential for blood clotting. They are produced by large
polyploid precursor cells called megakaryocytes. Previous genome-wide association studies …

The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibβ, GPV,
and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 …